These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1838416)

  • 1. The biochemical pharmacology of nogalamycin and its derivatives.
    Li LH; Krueger WC
    Pharmacol Ther; 1991; 51(2):239-55. PubMed ID: 1838416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menogaril: a new anthracycline agent entering clinical trials.
    McGovren JP; Nelson KG; Lassus M; Cradock JC; Plowman J; Christopher JP
    Invest New Drugs; 1984; 2(4):359-67. PubMed ID: 6239835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of intravenous menogaril in patients with previously untreated metastatic breast cancer. A National Cancer Institute of Canada Clinical Trials Group study.
    Eisenhauer EA; Pritchard KI; Perrault DJ; Verma S; Pater JL
    Invest New Drugs; 1990 Aug; 8(3):283-7. PubMed ID: 2148741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menogaril, an anthracycline compound with a novel mechanism of action: cellular pharmacology.
    Wierzba K; Sugimoto Y; Matsuo K; Toko T; Takeda S; Yamada Y; Tsukagoshi S
    Jpn J Cancer Res; 1990 Aug; 81(8):842-9. PubMed ID: 2144516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of menogaril as initial chemotherapy for metastatic breast cancer.
    Kennedy MJ; Donehower RC; Grochow LB; Ettinger DS; Fetting JH; Abeloff MD
    Invest New Drugs; 1990 Aug; 8(3):289-94. PubMed ID: 2148742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of menogaril in renal cell carcinoma. A Southwest Oncology Group phase II study (8504).
    Stephens RL; Goodman P; Crawford ED; Spicer CF; Lowe BA; Ahmann FR; Chapman R; Natale RB
    Invest New Drugs; 1990; 8 Suppl 1():S69-71. PubMed ID: 2143177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential poisoning of topoisomerases by menogaril and nogalamycin dictated by the minor groove-binding nogalose sugar.
    Sim SP; Gatto B; Yu C; Liu AA; Li TK; Pilch DS; LaVoie EJ; Liu LF
    Biochemistry; 1997 Oct; 36(43):13285-91. PubMed ID: 9341219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of intravenous menogaril in patients with advanced breast cancer.
    Sessa C; Gundersen S; ten Bokkel Huinink W; Renard J; Cavalli F
    J Natl Cancer Inst; 1988 Sep; 80(13):1066-9. PubMed ID: 2970554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II evaluation of menogaril in women with metastatic breast cancer after failure of first-line chemotherapy.
    Long HJ; Schaid DJ; Schutt AJ; Ingle JN; Loprinzi CL; Edmonson JH
    Am J Clin Oncol; 1988 Oct; 11(5):524-7. PubMed ID: 2972192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menogaril in the treatment of malignant mesothelioma: a phase II study.
    Hudis CA; Kelsen DP
    Invest New Drugs; 1992 Jul; 10(2):103-6. PubMed ID: 1386842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of oxygen free radical formation in the mechanism of menogaril resistance in multidrug resistant tumor cells.
    Sinha BK; Atwell J; Politi PM
    Chem Biol Interact; 1990; 76(1):89-99. PubMed ID: 2168296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
    Ohe Y; Nakagawa K; Fujiwara Y; Sasaki Y; Minato K; Bungo M; Niimi S; Horichi N; Fukuda M; Saijo N
    Cancer Res; 1989 Aug; 49(15):4098-102. PubMed ID: 2472873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of menogaril in patients with metastatic sarcomas and no prior chemotherapy exposure.
    Buckner JC; Edmonson JH; Ingle JN; Schaid DJ
    Am J Clin Oncol; 1989 Oct; 12(5):384-6. PubMed ID: 2529759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of menogaril in advanced malignant melanoma. An EORTC trial.
    Gundersen S; Monfardini S; Renard G; Van Glabbeke M; Pinedo H
    Eur J Cancer Clin Oncol; 1987 Nov; 23(11):1707-8. PubMed ID: 2962875
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II trial of menogaril in patients with advanced colorectal carcinoma: an Illinois Cancer Council trial.
    Locker GY; Kilton L; Hoeltgen T; Knop RH; Benson AB; Chernicoff D; Barrett J; Blough R; Johnson C
    Cancer Treat Rep; 1987 Sep; 71(9):871-2. PubMed ID: 2957053
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II trial of menogaril in adenocarcinoma of the pancreas. A Southwest Oncology Group study.
    Brown TD; Goodman PJ; Fleming TR; Baker LH; Macdonald JS
    Invest New Drugs; 1991 Feb; 9(1):77-8. PubMed ID: 1827433
    [No Abstract]   [Full Text] [Related]  

  • 17. A phase I study of menogaril in patients with advanced cancer.
    Brown TD; Donehower RC; Grochow LB; Rice AP; Ettinger DS
    J Clin Oncol; 1987 Jan; 5(1):92-9. PubMed ID: 2949065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative phase II trial of menogaril in advanced squamous, adeno- and large cell carcinoma of the lung.
    Joss RA; Monfardini S; Hansen M; Dombernowsky P; Renard J; Pinedo HM
    Eur J Cancer Clin Oncol; 1988 Feb; 24(2):263-5. PubMed ID: 2833403
    [No Abstract]   [Full Text] [Related]  

  • 19. A phase II study of menogaril (NSC-269148) in colorectal carcinoma. A Southwest Oncology Group study.
    Whitehead RP; Earhart RH; Fleming T; Goodman P; Macdonald JS; Pollock T; Ungerleider JS
    Invest New Drugs; 1990 Aug; 8(3):295-7. PubMed ID: 2148743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antitumor spectrum of TUT-7 on rat ascitic hepatoma].
    Satoh H; Taguchi H; Yahagi S
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):287-91. PubMed ID: 2137321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.